Cresco Labs Inc.
CRLBF- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001832928
No open-market purchases or sales by Cresco Labs Inc. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $122.7K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cresco Labs Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 16 | 1 | 16 | +1 |
| Shares | 692.8K | 137.2K | 517.7K | −37.9K (−6.8%) |
| Value | $1.80M | $402.0K | $1.41M | +$14.4K (+1.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Cresco Labs Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Monolith Advisors | 5,000 | $14.0K | 0.02% |
| Almanack Investment Partners, LLC. | 1,000 | $3.00K | 0.00% |
Sold out (1)
Institutions that held Cresco Labs Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Captrust Financial Advisors | 2,946 | $7.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Cresco Labs Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HighPoint Advisor Group LLC | 137,158 | $402.0K |